Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Study ID: NCT04872166
Start Date: 2021-06-07
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

112

Intervention / Treatment

BTX-A51

Sponsor

Edgewood Oncology Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of Language Interpretation Solutions for People With Breast Cancer

Study ID: NCT06721065
Start Date: 2024-12-02
End Date: 2029-12-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

640

Intervention / Treatment

Remote Simultaneous Medical Interpreting/RSMI

Remote Consecutive Medical Interpreting/RCMI

Remote Consecutive Video Medical Interpreting/RCVI

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

An Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms

Study ID: NCT05123365
Start Date: 2022-01-03
End Date: 2026-11-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

N-Acetylcysteine

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Study ID: NCT05926765
Start Date: 2023-06-13
End Date: 2025-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

AAV2-hAQP1 Concentration 1

AAV2-hAQP1 Concentration 2

Placebo

Sponsor

MeiraGTx, LLC

Source: clinicaltrials.gov

Share:
Add to list

Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer

Study ID: NCT06965166
Start Date: 2024-10-07
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

PCD-CT

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Study of Olutasidenib and Temozolomide in HGG

Study ID: NCT06161974
Start Date: 2025-03
End Date: 2035-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Olutedingib + TMZ

Sponsor

Rigel Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

Study ID: NCT06549465
Start Date: 2024-08-06
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

In-111 Rosopatamab Tetraxetan

45 Kabaqa/Kj

Kbaq/kg

60 Kabaka/Kj

Sponsor

Convergent Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

SynKIR-310 for Relapsed/Refractory B-NHL

Study ID: NCT06544265
Start Date: 2024-11-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Synkir-310

Sponsor

Verismo Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps

Study ID: NCT06376565
Start Date: 2023-11-08
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1680

Intervention / Treatment

Best Practice

Communication Intervention

Communication Intervention

Communication Intervention

Interview

Interview

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Study ID: NCT06376526
Start Date: 2024-08-21
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

Linvosamab

Sponsor

Dickran Kazandjian, MD

Source: clinicaltrials.gov

Share:
Add to list